RESEARCH-USE BIOSIMILAR ANTIBODY
Blosozumab
Monoclonal antibody · IgG4
Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis.
TARGETSOST
YMonoclonal antibody
CATALOGSC-BS-716
CATALOG NUMBERSC-BS-716
MOLECULAR WEIGHTApprox. 144.88 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis.
Blosozumab is a recombinant research-use antibody directed against SOST.